AssetMark’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
AssetMark's PRAX Position: Q3 2026 in Review
AssetMark increased its Praxis Precision Medicines (PRAX) stake by 135,400% in Q3 2026, buying an estimated $448K and bringing the position to 1,355 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.
AssetMark first reported a position in PRAX in Q4 2024 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- AssetMark held 1,355 shares of Praxis Precision Medicines worth $395K as of Q3 2026.
- AssetMark bought 1,354 Praxis Precision Medicines shares in Q3 2026, an estimated $448K.
- Praxis Precision Medicines made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1296 holding.
- AssetMark first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 3 quarters since.
- 241 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.